Skip to content
Search

Latest Stories

Boots and Superdrug may start selling Covid-19 vaccines soon

Boots and Superdrug may start selling Covid-19 vaccines soon

The high street retailers are in discussions with suppliers to offer a private Covid vaccination service in 2024, in collaboration with the government.

Like the flu jab, Covid-19 vaccines may be available for purchase from pharmacies in Britain in the coming months.


Two high street retailers, Boots and Superdrug, have revealed to The Times that they are collaborating with the government to start selling Covid jabs, which are currently only available from the NHS.

A Superdrug spokesman told the publication that they are in discussions with suppliers about “potentially offering a private Covid vaccination service in 2024.”

Boots, which already offers a range of vaccinations, including flu for both private and NHS customers, is also assessing various ways on how to offer private Covid vaccinations, a company’s spokesman informed The Times.

Moderna and Pfizer, two of the largest producers of the jab, have expressed their interest in providing their product to private operators, the report stated.

Currently, the flu jab is available in pharmacies and private clinics for between £10 and £20. At what price a Covid vaccine could be sold by high street retailers is still unknown.

Earlier in 2023, Moderna’s chief executive, Stéphane Bancel said that they were planning to sell its vaccines for $130, which is around £100.

Meanwhile, several countries, including the US, UK, China, and India, have reported a spike in Covid cases in recent weeks, due to the influx of a new strain of Covid known as JN.1.

Scientists at Japan's top research institute Riken have warned that this new variant could cause global 'heart failure pandemic'.

They explained that the ACE2 receptors, which the coronavirus uses for entry into human cells, are 'very common' in the heart, suggesting that many people infected with the virus may suffer from 'reduced cardiac function'.

With cases of Covid infection increasing in England and Scotland, the UK Health Security Agency (UKHSA) has urged all those eligible to get their seasonal Covid-19 vaccine before the window closes on 31 January 2024.

Latest data from the Winter Covid-19 Infection Study estimated that approximately one in every 24 people could test Covid positive at the current time in England and Scotland.

The highest prevalence regionally was found in London, with high rates of infection in people aged 18 to 44 years.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less